Multiple Directors Buy $DKNG Shares

📌 DraftKings $DKNG – Multiple directors filed Form 4s totaling $1,060,200.

Insiders are stepping in as the stock bounces off key support following a failed topping pattern.

It’s been under pressure for weeks, but this kind of cluster buying at a key level stands out.

📌 Opendoor $OPEN – CEO Kaz Nejatian purchased little over $1 million per a new Form 4.

Momentum has kicked in again — and the CEO's timing couldn’t be more interesting.

Here’s The Hot Corner, with data from November 12, 2025:

Click the table to enlarge it.

📌 Novavax $NVAX – Shah Capital raised its 13D from 7.27% to 8.30%.

The activist-leaning fund continues tightening its grip as the stock struggles to base out after years of pain. A small sign of conviction in a name still trying to find its footing.

📌 BioCryst $BCRX – RA Capital filed an original 13G at 7.30%.

A credible biotech specialist taking a position in a name still working through a long bottoming process. BCRX is basing — but needs more time to prove it’s ready to turn the corner.

📌 Rep. Michael McCaul — Disclosed a series of diversified  large-cap buys including $GPN, $IFF, $NFG, $DLTR, $LDNXF, $ST, $GOOGL.

A diversified mix of blue chips tilted toward payments, chemicals, and industrial.